|
US315810A
(en)
|
|
1885-04-14 |
|
Gael mbistee |
|
US318694A
(en)
|
|
1885-05-19 |
|
Bread-cutter |
|
US318482A
(en)
|
|
1885-05-19 |
|
Key-ring |
|
US315861A
(en)
|
|
1885-04-14 |
|
New jebsey |
|
US15677A
(en)
*
|
|
1856-09-02 |
|
Improved cutting device for harvesters |
|
US4294926A
(en)
|
1979-06-15 |
1981-10-13 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
US4319039A
(en)
|
1979-06-15 |
1982-03-09 |
Merck & Co., Inc. |
Preparation of ammonium salt of hypocholesteremic fermentation product
|
|
US4444784A
(en)
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
MX7065E
(es)
|
1980-06-06 |
1987-04-10 |
Sankyo Co |
Un procedimiento microbiologico para preparar derivados de ml-236b
|
|
JPS5889191A
(ja)
|
1981-11-20 |
1983-05-27 |
Sankyo Co Ltd |
３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
|
|
US5354772A
(en)
|
1982-11-22 |
1994-10-11 |
Sandoz Pharm. Corp. |
Indole analogs of mevalonolactone and derivatives thereof
|
|
WO1984002131A1
(fr)
|
1982-11-22 |
1984-06-07 |
Sandoz Ag |
Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
|
|
US4911165A
(en)
|
1983-01-12 |
1990-03-27 |
Ethicon, Inc. |
Pliabilized polypropylene surgical filaments
|
|
US4681893A
(en)
|
1986-05-30 |
1987-07-21 |
Warner-Lambert Company |
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
|
|
US4885314A
(en)
|
1987-06-29 |
1989-12-05 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
|
US4782084A
(en)
|
1987-06-29 |
1988-11-01 |
Merck & Co., Inc. |
HMG-COA reductase inhibitors
|
|
US4820850A
(en)
|
1987-07-10 |
1989-04-11 |
Merck & Co., Inc. |
Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
|
|
US5030447A
(en)
|
1988-03-31 |
1991-07-09 |
E. R. Squibb & Sons, Inc. |
Pharmaceutical compositions having good stability
|
|
US5180589A
(en)
|
1988-03-31 |
1993-01-19 |
E. R. Squibb & Sons, Inc. |
Pravastatin pharmaceuatical compositions having good stability
|
|
US4916239A
(en)
|
1988-07-19 |
1990-04-10 |
Merck & Co., Inc. |
Process for the lactonization of mevinic acids and analogs thereof
|
|
US5290946A
(en)
|
1988-10-13 |
1994-03-01 |
Sandoz Ltd. |
Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
|
|
US5118853A
(en)
|
1988-10-13 |
1992-06-02 |
Sandoz Ltd. |
Processes for the synthesis of 3-disubstituted aminoacroleins
|
|
US4929437A
(en)
|
1989-02-02 |
1990-05-29 |
Merck & Co., Inc. |
Coenzyme Q10 with HMG-CoA reductase inhibitors
|
|
US5189164A
(en)
|
1989-05-22 |
1993-02-23 |
Sandoz Ltd. |
Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
|
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
|
PH27357A
(en)
|
1989-09-22 |
1993-06-21 |
Fujisawa Pharmaceutical Co |
Pyrazole derivatives and pharmaceutical compositions comprising the same
|
|
US5420245A
(en)
|
1990-04-18 |
1995-05-30 |
Board Of Regents, The University Of Texas |
Tetrapeptide-based inhibitors of farnesyl transferase
|
|
US5475085A
(en)
|
1991-02-07 |
1995-12-12 |
Molecumetics, Ltd. |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
|
HU9203780D0
(en)
|
1991-12-12 |
1993-03-29 |
Sandoz Ag |
Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
|
|
US5604260A
(en)
|
1992-12-11 |
1997-02-18 |
Merck Frosst Canada Inc. |
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
|
|
EP0604181A1
(en)
|
1992-12-21 |
1994-06-29 |
Eli Lilly And Company |
Antitumor compositions and method of treatment
|
|
DE9422447U1
(de)
|
1993-01-15 |
2002-10-17 |
G.D. Searle LLC, Chicago, Ill. |
3,4-Diarylthiophene und Analoga davon, sowie deren Verwendung als entzündungshemmende Mittel
|
|
WO1994019357A1
(en)
|
1993-02-23 |
1994-09-01 |
Merrell Dow Pharmaceuticals Inc. |
Farnesyl:protein transferase inhibitors as anticancer agents
|
|
US5298627A
(en)
|
1993-03-03 |
1994-03-29 |
Warner-Lambert Company |
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
|
|
US5409944A
(en)
|
1993-03-12 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
|
|
CA2118985A1
(en)
|
1993-04-02 |
1994-10-03 |
Dinesh V. Patel |
Heterocyclic inhibitors of farnesyl protein transferase
|
|
WO1994026723A2
(en)
|
1993-05-14 |
1994-11-24 |
Genentech, Inc. |
ras FARNESYL TRANSFERASE INHIBITORS
|
|
US5602098A
(en)
|
1993-05-18 |
1997-02-11 |
University Of Pittsburgh |
Inhibition of farnesyltransferase
|
|
US5380738A
(en)
|
1993-05-21 |
1995-01-10 |
Monsanto Company |
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
|
|
GB9602877D0
(en)
|
1996-02-13 |
1996-04-10 |
Merck Frosst Canada Inc |
3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors
|
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
|
US5436265A
(en)
|
1993-11-12 |
1995-07-25 |
Merck Frosst Canada, Inc. |
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
|
|
WO1995008542A1
(en)
|
1993-09-22 |
1995-03-30 |
Kyowa Hakko Kogyo Co., Ltd. |
Farnesyltransferase inhibitor
|
|
DE69429440T2
(de)
|
1993-10-15 |
2002-08-08 |
Schering Corp., Kenilworth |
Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen
|
|
IL111235A
(en)
|
1993-10-15 |
2001-03-19 |
Schering Plough Corp |
Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
|
|
US5721236A
(en)
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
ZA947970B
(en)
|
1993-10-15 |
1996-07-12 |
Schering Corp |
Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5661152A
(en)
|
1993-10-15 |
1997-08-26 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US5719148A
(en)
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
FI961621L
(fi)
|
1993-10-25 |
1996-04-12 |
Parke Davis & Co |
Proteiini:farnesyylitranseraasin substituoidut tetra- ja pentapeptidi-inhibiittorit
|
|
US5344991A
(en)
|
1993-10-29 |
1994-09-06 |
G.D. Searle & Co. |
1,2 diarylcyclopentenyl compounds for the treatment of inflammation
|
|
DK0677039T3
(da)
|
1993-11-04 |
1999-09-27 |
Abbott Lab |
Cyclobutanderivater som squalen-syntetase- og protein-farnesyltransferaseinhibitorer
|
|
US5783593A
(en)
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
|
KR100362338B1
(ko)
|
1993-11-05 |
2003-04-08 |
워너-램버트 캄파니 |
단백질:파르네실트랜스퍼라아제의치환디-및트리펩티드억제제
|
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
|
CZ291950B6
(cs)
|
1993-12-07 |
2003-06-18 |
Eli Lilly And Company |
Bis-indolmaleinimidy, jako inhibitory proteinové kinázy C, léčivo, farmaceutický prostředek s jejich obsahem a jejich použití
|
|
US5484799A
(en)
|
1993-12-09 |
1996-01-16 |
Abbott Laboratories |
Antifungal dorrigocin derivatives
|
|
EP0817627B1
(en)
|
1993-12-23 |
2005-03-09 |
Eli Lilly And Company |
Protein kinase c inhibitors
|
|
US5545636A
(en)
|
1993-12-23 |
1996-08-13 |
Eli Lilly And Company |
Protein kinase C inhibitors
|
|
US5393790A
(en)
|
1994-02-10 |
1995-02-28 |
G.D. Searle & Co. |
Substituted spiro compounds for the treatment of inflammation
|
|
WO1995024612A1
(de)
|
1994-03-07 |
1995-09-14 |
International Business Machines Corporation |
Verfahren und vorrichtung zur schnellen interpolation von zwischenwerten aus periodischen phasenverschobenen signalen und zur erkennung von defekten in einem drehkörper
|
|
FI963597L
(fi)
|
1994-03-15 |
1996-11-14 |
Eisai Co Ltd |
Isoprenyylitransferaasi-inhibiittoreita
|
|
RU95104898A
(ru)
|
1994-03-31 |
1996-12-27 |
Бристоль-Мейерз Сквибб Компани (US) |
Имидазолсодержащие ингибиторы фарнезид-протеинтрансферазы, способ лечения связанных с ней заболеваний
|
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
|
US5510510A
(en)
|
1994-05-10 |
1996-04-23 |
Bristol-Meyers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5563255A
(en)
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
CA2192389A1
(fr)
|
1994-06-10 |
1995-12-21 |
Bernard Baudoin |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5571792A
(en)
|
1994-06-30 |
1996-11-05 |
Warner-Lambert Company |
Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
|
|
WO1996005529A1
(en)
|
1994-08-09 |
1996-02-22 |
Micron Optics, Inc. |
Temperature compensated fiber fabry-perot filters
|
|
CA2155448A1
(en)
|
1994-08-11 |
1996-02-12 |
Katerina Leftheris |
Inhibitors of farnesyl protein transferase
|
|
DE69514367T2
(de)
|
1994-08-11 |
2000-07-27 |
Banyu Pharmaceutical Co., Ltd. |
Substituierte amidderivate
|
|
EP0805154A1
(en)
|
1994-08-12 |
1997-11-05 |
Banyu Pharmaceutical Co., Ltd. |
N,n-disubstituted amic acid derivative
|
|
DE4429506B4
(de)
|
1994-08-19 |
2007-09-13 |
Degussa Gmbh |
Verfahren zur Extraktion natürlicher Carotinoid-Farbstoffe
|
|
DE4429653C2
(de)
|
1994-08-20 |
1997-04-03 |
Anton Dr More |
Konverter und Verfahren zum Frischen von Metallschmelzen insbesondere von Roheisen zu Stahl
|
|
JP4319251B2
(ja)
|
1994-11-22 |
2009-08-26 |
エヌエックスピー ビー ヴィ |
半導体素子を有し導体トラックが形成されている基板が接着層により結合されている支持本体を有する半導体装置
|
|
AU3971295A
(en)
|
1994-12-09 |
1996-06-26 |
Warner-Lambert Company |
Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
|
|
EA000164B1
(ru)
|
1995-01-09 |
1998-10-29 |
Магла Интернэшнл Лтд. |
Состав для печати изображения на поверхности изделия из каучукового латекса, способ печати изображения и изделия из каучукового латекса
|
|
JP3929069B2
(ja)
|
1995-01-12 |
2007-06-13 |
ユニバーシティ オブ ピッツバーグ |
プレニルトランスフェラーゼの阻害剤
|
|
FR2729390A1
(fr)
|
1995-01-18 |
1996-07-19 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2730491B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2730492B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5633272A
(en)
|
1995-02-13 |
1997-05-27 |
Talley; John J. |
Substituted isoxazoles for the treatment of inflammation
|
|
US5684013A
(en)
|
1995-03-24 |
1997-11-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5700806A
(en)
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
|
WO1996031501A1
(en)
|
1995-04-07 |
1996-10-10 |
Schering Corporation |
Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
|
|
US5712280A
(en)
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
IL117798A
(en)
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
|
US5891872A
(en)
|
1995-04-07 |
1999-04-06 |
Schering Corporation |
Tricyclic compounds
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
IL118101A0
(en)
|
1995-05-03 |
1996-09-12 |
Abbott Lab |
Inhibitors of farnesyltransferase
|
|
AU6034296A
(en)
|
1995-06-16 |
1997-01-15 |
Warner-Lambert Company |
Tricyclic inhibitors of protein farnesyltransferase
|
|
FR2736641B1
(fr)
|
1995-07-10 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
AT402617B
(de)
|
1995-07-11 |
1997-07-25 |
Datacon Schweitzer & Zeindl Gm |
Anlage zum automatisierten, hermetischen anlage zum automatisierten, hermetischen verschliessen von gehäusen verschliessen von gehäusen
|
|
FR2736638B1
(fr)
|
1995-07-12 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
CH690163A5
(fr)
|
1995-07-28 |
2000-05-31 |
Symphar Sa |
Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers.
|
|
US6020343A
(en)
|
1995-10-13 |
2000-02-01 |
Merck Frosst Canada, Inc. |
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
|
|
ATE236632T1
(de)
|
1995-11-06 |
2003-04-15 |
Univ Pittsburgh |
Inhibitoren der protein-isoprenyl-transferase
|
|
ATE218556T1
(de)
|
1995-11-17 |
2002-06-15 |
Biotechnolog Forschung Gmbh |
Epothilon-derivate und deren herstellung
|
|
IL124417A
(en)
|
1995-11-20 |
2002-11-10 |
Lilly Co Eli |
Dietary salt of -13 [(dimethyl amino) methyl] - 10, 11, 14, 15 - tetra hydro- 4, 9:16, 21 - our image - H13, H1 - Divenzo {E, K} pyrrole [H-4, 3] [1, 4, 13] Oxadiazacyclohexadecin - 1, 3 (H2) - Discussion, preparation and pharmacological preparations for the inhibition of protein kinase C containing it
|
|
CA2238081A1
(en)
|
1995-11-22 |
1997-05-29 |
S. Jane Desolms |
Inhibitors of farnesyl-protein transferase
|
|
CN1101392C
(zh)
|
1995-12-08 |
2003-02-12 |
詹森药业有限公司 |
抑制法呢基蛋白质转移酶的(咪唑－5－基)甲基－2－喹啉酮衍生物
|
|
ES2248826T3
(es)
|
1995-12-22 |
2006-03-16 |
Schering Corporation |
Amidas triciclicas utiles para la inhibicion de la funcion de la proteina g y para el tratamiento de enfermedades proliferativas.
|
|
WO1997026246A1
(en)
|
1996-01-16 |
1997-07-24 |
Warner-Lambert Company |
Substituted histidine inhibitors of protein farnesyltransferase
|
|
US6673927B2
(en)
|
1996-02-16 |
2004-01-06 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Farnesyl transferase inhibitors
|
|
JP2001519766A
(ja)
|
1996-04-03 |
2001-10-23 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシルタンパク質トランスフェラーゼの阻害剤
|
|
RO121338B1
(ro)
|
1996-04-12 |
2007-03-30 |
G.D. Searle & Co. |
Derivaţi de benzensulfonamidă, procedeu de preparare a acestora, compoziţie farmaceutică şi utilizarea ca inhibitori de cox-2
|
|
CN1219174A
(zh)
|
1996-05-22 |
1999-06-09 |
沃尼尔·朗伯公司 |
蛋白质法呢基转移酶的抑制剂
|
|
AU709409B2
(en)
|
1996-07-15 |
1999-08-26 |
Bristol-Myers Squibb Company |
Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
|
|
US5861419A
(en)
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
|
AU756699B2
(en)
|
1996-12-03 |
2003-01-23 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
|
AU6013998A
(en)
|
1996-12-30 |
1998-07-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JP2001507699A
(ja)
|
1996-12-30 |
2001-06-12 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白トランスフェラーゼ阻害薬
|
|
EP1151002A4
(en)
|
1999-01-29 |
2002-05-02 |
Imclone Systems Inc |
KDR-SPECIFIC ANTIBODIES AND USES THEREOF
|
|
GB9904387D0
(en)
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
|
AU4972900A
(en)
|
1999-04-08 |
2000-11-14 |
Arch Development Corporation |
Use of anti-vegf antibody to enhance radiation in cancer therapy
|
|
PL203998B1
(pl)
|
1999-10-27 |
2009-11-30 |
Cytokinetics Inc |
Nowy związek chinazolinowy, zastosowanie związku chinazolinowego, sposób jego otrzymywania i kompozycja farmaceutyczna zawierająca związek chinazolinowy
|
|
US6545004B1
(en)
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
AU2001231143A1
(en)
|
2000-01-27 |
2001-08-07 |
Cytovia, Inc. |
Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
US6737957B1
(en)
|
2000-02-16 |
2004-05-18 |
Verance Corporation |
Remote control signaling using audio watermarks
|
|
US6645970B2
(en)
|
2000-11-07 |
2003-11-11 |
Novartis Ag |
Indolylmaleimide derivatives
|
|
DK1337527T3
(da)
|
2000-11-07 |
2010-01-04 |
Novartis Ag |
Indolylmaleinimidderivater som proteinkinase C-inhibitorer
|
|
JP2004527531A
(ja)
|
2001-04-10 |
2004-09-09 |
メルク エンド カムパニー インコーポレーテッド |
癌を治療する方法
|
|
WO2002083139A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
WO2002083140A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
DE60227492D1
(de)
|
2001-04-10 |
2008-08-21 |
Merck & Co Inc |
Hemmstoffe der akt aktivität
|
|
SE0102439D0
(sv)
*
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
SE0102438D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
WO2003013526A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co. Inc. |
Anticoagulant compounds
|
|
JP2005511581A
(ja)
|
2001-11-07 |
2005-04-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
|
DE60232994D1
(de)
|
2001-12-06 |
2009-08-27 |
Merck & Co Inc |
Inhibitoren von mitotischem kinesin
|
|
US7378411B2
(en)
|
2001-12-06 |
2008-05-27 |
Merck & Co., Inc. |
Substituted thienopyrimidinones as a mitotic kinesin inhibitor
|
|
EP1465896A4
(en)
|
2001-12-06 |
2006-01-11 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESINE
|
|
JP4467979B2
(ja)
|
2001-12-06 |
2010-05-26 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有糸分裂キネシン阻害剤
|
|
EP1551812B1
(en)
|
2001-12-06 |
2009-03-04 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
AR039209A1
(es)
|
2002-04-03 |
2005-02-09 |
Novartis Ag |
Derivados de indolilmaleimida
|
|
SE0203754D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
|
CA2536964A1
(en)
|
2003-04-25 |
2004-11-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
C-fms kinase inhibitors
|
|
EP1715867A4
(en)
|
2004-02-12 |
2009-04-15 |
Merck & Co Inc |
BIPYRIDYLAMIDE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5
|
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
CA2584485C
(en)
|
2004-10-20 |
2013-12-31 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
WO2006048771A1
(en)
|
2004-11-04 |
2006-05-11 |
Addex Pharmaceuticals Sa |
Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
|
|
RU2008104510A
(ru)
|
2005-07-11 |
2009-08-20 |
Новартис АГ (CH) |
Производные индолилмалеинимида
|
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
|
MX2009008434A
(es)
*
|
2007-02-08 |
2009-08-17 |
Univ California |
Mutaciones de gnaq en melanoma.
|
|
CA2679659C
(en)
*
|
2007-03-01 |
2016-01-19 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
|
NZ582708A
(en)
|
2007-07-19 |
2012-04-27 |
Schering Corp |
Heterocyclic amide compounds as protein kinase inhibitors
|
|
PE20091309A1
(es)
|
2007-12-21 |
2009-09-30 |
Astrazeneca Ab |
Derivados de ciclohexilo como inhibidores de acetil coenzima a carboxilasa
|
|
US8168794B2
(en)
|
2008-03-03 |
2012-05-01 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
|
US8460743B2
(en)
|
2008-03-18 |
2013-06-11 |
Novartis Ag |
Coating process for ophthalmic lenses
|
|
BRPI0918268B1
(pt)
|
2008-09-02 |
2021-08-03 |
Novartis Ag |
Derivados de picolinamida, seu uso, e composição farmacêutica
|
|
WO2010046780A2
(en)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
|
US8703962B2
(en)
|
2008-10-24 |
2014-04-22 |
Purdue Pharma L.P. |
Monocyclic compounds and their use as TRPV1 ligands
|
|
EP2376485B1
(en)
|
2008-12-19 |
2017-12-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazine derivatives useful as inhibitors of atr kinase
|
|
SG172353A1
(en)
|
2008-12-23 |
2011-07-28 |
Abbott Lab |
Anti-viral compounds
|
|
WO2010144345A1
(en)
|
2009-06-08 |
2010-12-16 |
Abraxis Bioscience, Llc |
Triazine derivatives and their therapeutical applications
|
|
US8415381B2
(en)
|
2009-07-30 |
2013-04-09 |
Novartis Ag |
Heteroaryl compounds and their uses
|
|
US20120165306A1
(en)
*
|
2009-09-04 |
2012-06-28 |
Barsanti Paul A |
Pyrazinylpyridines useful for the treatment of proliferative diseases
|
|
CA2780759A1
(en)
|
2009-12-01 |
2011-06-09 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
|
WO2011120911A1
(en)
*
|
2010-03-30 |
2011-10-06 |
Novartis Ag |
Pkc inhibitors for the treatment of b-cell lymphoma having chronic active b-cell-receptor signalling
|
|
EP2590968A1
(en)
*
|
2010-07-06 |
2013-05-15 |
Novartis AG |
Cyclic ether compounds useful as kinase inhibitors
|
|
US20140031547A1
(en)
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
|
WO2012101064A1
(en)
|
2011-01-28 |
2012-08-02 |
Novartis Ag |
N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
|
|
US20120225061A1
(en)
|
2011-03-04 |
2012-09-06 |
Matthew Burger |
Tetrasubstituted cyclohexyl compounds as kinase inhibitors
|
|
UY33930A
(es)
*
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
KR101410902B1
(ko)
|
2011-07-27 |
2014-06-20 |
아스트라제네카 아베 |
암 치료에 유용한 egfr 조절물질로서 2-(2,4,5-치환된-아닐리노)피리미딘 유도체
|
|
US8987457B2
(en)
*
|
2012-05-21 |
2015-03-24 |
Novartis Ag |
Ring-substituted N-pyridinyl amides as kinase inhibitors
|
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
|
US20150336960A1
(en)
|
2012-12-19 |
2015-11-26 |
Novartis Ag |
Aryl-substituted fused bicyclic pyridazine compounds
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
JO3589B1
(ar)
*
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
|
WO2019053595A1
(en)
*
|
2017-09-12 |
2019-03-21 |
Novartis Ag |
INHIBITORS OF PROTEIN KINASE C FOR THE TREATMENT OF CHOROIDAL MELLANOMA
|